Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Creators
Terry
@terrybenedict8· 18 followers+2 more creators
Launched
8y ago
2018-06-19 · Est.

Traffic

Monthly visitsData through Sep 2026 · Oct 2026 pending
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Generate investment ideas by following insiders

    Oct 31 · 15d agoLaunch page

    At the time: <5K visits/mo
  • Launched on Product HuntLaunch

    Generate investment ideas by following insiders

    Sep 11, 2025 · 14mo agoLaunch page

  • Launched on Product HuntLaunch

    Generate investment ideas by following insiders

    Jul 31, 2025 · 16mo agoLaunch page

  • Launched on Product HuntLaunch

    Access ShareSEER data from Claude

    Jul 10, 2025 · 16mo agoLaunch page

  • Launched on Product HuntLaunch

    Investment Research made simple

    May 16, 2025 · 18mo agoLaunch page

Third-party reviews & case dossiers

Acquisition breakdowns, engineer reviews & open-source metrics
Show HN
2018-06-20Source
Post excerpt:
ShareSEER is a research tool for investors. We are excited to announce the launch V 1.3 of ShareSEER. We now have: - A real time insider filing dashboard - https://shareseer.com/today/insiders . View live sales and purchases of stocks by company insiders! Get information one day faster than in major brokerages. Filter by existing companies. - A risk extracto

MCP Server & Agent Ecosystem

GitHub · MCP / Skill

Agent, MCP & Developer Integration

MCP ServerAPI
Ecosystem & integrations:
Claude
Browse all MCP Server products →

Store data

Chrome Web Store
Chrome Web Store Chrome Web Store
Update date not synced
Rating
Rating not syncedRating count not synced
New ratings last mo
—
Price & IAP
FreeIAP data not synced
Current version
—Store metadata

Store assets, rating histograms, install tiers, and screenshots are synced from Apple App Store, Google Play, and Chrome Web Store.

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search22%
  • Referrals10%
  • Display Ads7%
  • Other22%

Countries

  • United States73%
  • South Africa27%

Search

Domain authority —Domain registered 2018-02-20

KeywordMonthly volume
amazon investor relations2,900
amazon annual report1,300
nvidia 10k970
msft investor relations410
berkshire hathaway 10-k330

Traffic data: Vaneform

Pricing

Free Research
Unknown
Insider trades, 13F holdings, and 10-K/10-Q/8-K filings · Insider dashboards and cluster research · Email alerts for up to 10 companies and funds combined · Financial statement downloads
Free Developer
Unknown
30 requests/hour and 100/day, shared across API and MCP · Latest available published data · 24 months of company-filing history
Production Access
Contact sales
Agreed request allowances · Available deeper company-filing history

Trial: None · Enterprise custom tier · Observed 2026-11-04 · Pricing page

Pages & changes

Tracked since 2019-04-22

Key pages

Weekly snapshots
shareseer.com/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does ShareSEER cost?
Free Research: Unknown; Free Developer: Unknown; Production Access: Contact sales. Observed 2026-11-04. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does ShareSEER get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is ShareSEER and what platforms does it support?
ShareSEER is catalogued under Financial Data & Research: Track What Insiders Trade. In Real-Time.. Supported platforms: Browser Extension, MCP Server, API.

Related products in this category

Finance / Financial Data & Research

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.